Clinical Trials on Killer-cell Immunoglobulin-like Receptors (KIRs) in Ireland
Total 0 results
Nothing found
Sponsors and Collaborators
- Zhejiang Provincial Hospital of TCM
- Intrinsic Imaging, LLC
- Hepatitis C Trust
- EndoPhotonix, Inc.
- Kyoto Drug Discovery and Development Co., Ltd.
- Riverside Hospital Foundation
- Christoph Czarnetzki
- Federal Agency for Nuclear Control, Belgium
- Groupe Hospitalier Pitie-Salpetriere
- Translational Research in Oncology-U.S. Inc. (TRIO-US)
- Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
- Alexander Shayesteh
- Paula Simplicio da Silva, MSc PhD student
- Loay Abdulmutalib Almusawi
- Anthony Hanley
- TR Therapeutics
- Orthox Limited
- Academy of Military Medical Sciences，Academy of Military Sciences，PLA ZHONGYIANKE Biotech Co, Ltd. LIAONINGMAOKANGYUAN Biotech Co, Ltd
- Xavier Serra-Aracil
- Jeffrey Rudolph
- View Full List
Medical Conditions
- Weight, Birth
- High Anal Fistula
- Chronic Myeloid Leukemia (CML-BP)
- Bariatric Patients
- Patients Requiring Urgent Vascular Access
- Patients With BRAFV600 E or BRAFV600K Mutation
- Type II Diabetes in Subjects BMI 27 to 32
- Pediatric Hospitalization
- Partial Supraspinatus Tear
- Mental Health Conditions
- Metabolic Syndromes
- Rolling Scars
- Plasma Concentration Change of Quetiapine
- Castration-resistant Prostate Cancer (CRPC)
- ROS1 Gene Rearrangement
- Compare Central Line Insertion of Subclavian Vein With Two Different Approaches Using Ultrasound
- Establish the Possible Interaction Between Biomarkers and Resonance in Different Prostate Biopsy Models to Define Tumor Presence and / or Tumor Aggressiveness
- Sagittal Alignment
- Same-day Discharge
- Fasting, Intermittent
- View Full List
Drug Interventions
- CTA101
- Taxane (docetaxel or paclitaxel)
- ASP2713
- Salbutamol
- AMR101
- S-1
- Fluorouracil based chemotherapy regimens
- Nonsteroidal (Acular, Voltaren Xibrom, etc)
- Vehicle solution
- Pharmacologic agents (e.g. LMWH/VKA/Fondaparinux/Aspirin and etc.)
- Aceclidine
- Citrulline
- Treatment B
- One out of 140 predefined homeopathic medical products (HMP) in potency C200 or C1000,
- Implanon immediately postpartum
- Amlessa®
- Azilect®
- Toradol
- Crizotinib
- Corneal crosslinking without the application of 0.02% MMC
- View Full List
CROs by country
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Chile
- Contract Research Organizations in Colombia
- Contract Research Organizations in Ecuador
- Contract Research Organizations in France
- Contract Research Organizations in Gambia
- Contract Research Organizations in Greece
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Mali
- Contract Research Organizations in Slovenia
- Contract Research Organizations in South Korea
- Contract Research Organizations in Sweden
- Contract Research Organizations in Togo
- CRO list by country